Abstract
Numerous epidemiologic studies have shown that the prevalence of some rheumatologic manifestations increases in diabetic patients. Limited joint mobility, part of the thick skin syndrome that we describe in detail in this chapter, is considered an important marker of subsequent microvascular disease and can constitute a useful clinical tool for the identification of a subset of patients at high risk to develop early complications.
Access provided by CONRICYT-eBooks. Download chapter PDF
Similar content being viewed by others
Keywords
- Limited joint mobility
- Finger pebbles
- Advanced glycation end-products
- Diabetic hand
- Thick skin syndrome
- Scleredema diabeticorum
- Diabetic sclerodermiform changes
- Rheumatological Manifestations
- Stiff skin syndrome
Introduction
Diabetic patients show higher prevalence of rheumatic diseases as compared to general population due to the fact that Diabetes Mellitus (DM) affects all components of musculoskeletal system: muscles, bones and connective tissue [1, 2].
Different musculoskeletal disorders that involve hands and shoulders are described, including palmar flexor tenosynovitis, Dupuytren’s contracture , carpal tunnel syndrome, Charcot arthropathy, reflex sympathetic dystrophy and shoulder’s adhesive capsulitis. They can be painful and cause functional weakness (Figs. 7.1 and 7.2) [3, 4].
In the hand, DM produces the so-called “diabetic hand syndrome ”, being Limited joint mobility (LJM) the most frequent manifestation [5]. It is rather underexposed and underdiagnosed compared with other well-known manifestations of the disease. It’s association with neuropathy and microvascular complications, should alert the physician about higher risk for the development of “Diabetic foot Syndrome” among other pathologies that can influence patients’ health-related quality of life quite dramatically [6]. Prevalence of LJM increases with duration of DM, poor glycemic control, non-enzymatic glycation (NEG) and accumulation of advanced glycation end products (AGEs) , increasing age and also in smokers [7, 8].
The thick skin syndrome includes four cutaneous manifestations: Finger pebbles (FP); Waxy skin (WS); Limited joint mobility (LJM); and Diabetic scleredema (DS) (Table 7.1) [9].
Finger Pebbles
Also known as Huntley’s papules , FP consist of multiple tiny papules grouped on the extensor surface and lateral aspect of the fingers, on the knuckles of the metacarpophalangeal and interphalangeal joints, more frequently in the distal ones, and in the periungual region (Figs. 7.3, 7.4 and 7.5) [10, 11].
According to the literature, it is a very common finding that reaches up to 60–70% of diabetic patients, but in our experience, we do not find it so often. Moreover, it can happen in 20% of non-diabetic people, especially, manual workers. It is asymptomatic, and treatment is not required.
When it appears in diabetic patients, it is considered a visual marker of the thickening of the dorsum of the hands. It is associated with either type 1 DM (T1DM) or type 2 DM (T2DM) of both genders equally; although in Huntley’s original description—later supported by other authors—it is more frequent in adults with T2DM. It has been suggested that the thickening is not only related to NEG of collagen fibers, but also to epidermal growth factors such as insulin-like growth factor (IGF-1) [12]. Finger pebbles are an early dermatologic sign of sclerodermiform alterations in hands [13].
The histologic features of FP are epidermal hyperplasia with a “church tower” aspect where orthokeratotic hyperkeratosis and regular acanthosis are evident; at the dermis level, we observe changes in the collagen fibers that are arranged vertically, papillomatosis and areas of angiogenesis along with insignificant perivascular infiltrates [14].
Saraiya et al. described an association between FP, acanthosis nigricans (AN) and cutaneous acrochordons in obese T2DM patients with insulin resistance (IR) and high levels of IGF-1 [15, 16]. FP are also associated to severe obesity in the context of IR without underlying DM, as in the reported case by Granel et al., whose patient suffers from Pickwick Syndrome (severe obesity, drowsiness, excessive appetite, hypoventilation, and sleep apnea) [17].
Waxy Skin
It is characterized by cutaneous changes over the dorsum of the hands and forearm due to the accumulation of dermal collagen of the skin. Under physical examination the skin is shiny and tight, difficult to fold, similar to scleroderma but with its own features, both in optical and electron microscopy. Clinical manifestations such as ulcers and Raynaud’s phenomenon, capillaroscopic Scleroderma pattern, specific autoantibodies and other laboratory data are helpful in the differential diagnosis between both entities (Table 7.2) (Figs. 7.6 and 7.7) [18].
Waxy skin is more frequent in diabetic patients with LJM, in particular with those with moderate or severe involvement, than in diabetic individuals without that manifestation, which in turn, have thicker skin compared to non-diabetics. Histopathologically, dermoepidermal thickening with accumulation of collagen and loss of cutaneous appendages are characteristic features.
Limited Joint Mobility
LJM is caused by the thickening and stiffness of the periarticular connective tissue. It involves mainly the small joints of the hands and results in a severe finger contracture and the inability to extend the metacarpophalangeal and proximal and distal interphalangeal joints starting with the fifth and fourth fingers and expanding radially. It is painless and generally goes unnoticed until the deformity becomes so severe that it interferes with daily life with less grip strength and a notable difficulty to close the fingers into a fist and make fine movements (Figs. 7.8, 7.9, 7.10, 7.11, 7.12, 7.13, 7.14, 7.15, 7.16 and 7.17).
It is also known as cheiroarthropathy or “diabetic stiff hand syndrome” and has a prevalence of 30–40% of T1DM patients (8–50% of diabetic individuals); although it is also present in T2DM, both male and female equally.
Apart from the hands, other joints can be affected like wrists, elbows, knees, ankles, shoulders, the cervical and thoracolumbar spine, and other organs (lungs) [19]. Its original description on the 70s belongs to Rosembloom et al., where they reported three cases with long-lasting T1DM and LJM of the hands, wrists, elbows and ankles and in two of them along spinal column with other clinical features. X-rays did not show any joint disorders, which confirmed that the thickening was due to the thickening and stiffness of the periarticular tissue [20].
The main risk factor for the appearance of this disease is the DM duration [21]. There is a relationship between joint stiffness and increased NEG of periarticular collagen, cartilage and tendon, based on the proof that each increased unit of HbA1c from the beginning of the disease, corresponded to 46% of increase risk of developing LJM.
It is essential to emphasize that the presence of LJM in diabetic patients is an important marker of subsequent microvascular disease and can constitute a useful clinical tool for the identification of a subset of patients at high risk for developing early complications.
Some authors refer that LJM is an independent factor for the development of microvascular complications and increases the risk 3–5 times in these patients. A recent analysis found that in the presence of LJM, there is an 83% increase in the risk of developing microvascular complications after 16 years of having DM, as opposed to 25% of risk in the absence of LJM. Rosenbloom et al. observed that it is even more frequent in the case of the male gender, possibly due to a poor glycemic control, coronary heart and cerebrovascular disease. In women, it is related to early macrovascular complications [22].
In addition, LJM is associated with several disorders that should be taken into account such as higher risk of accidental falls—which is moderate according to balance assessment (19–20 s), and diabetic foot ulcers, due to an increase of the pressure on the metatarsophalangeal and submetatarsal joints plantar points [23, 24].
Thickening of the plantar fascia and the Achilles tendon, has also been described, more frequently in patients having LJM and peripheral neuropathy and correlated positively with the body mass index (BMI) [25]. Moreover, shoulder and hand’s LJM may lead to upper extremity impairments compromising the strength and functionality of the upper extremity [26].
The degree of hand involvement has been classified into mild, when the limitation affects one or two proximal interphalangeal joints, one large joint or only metacarpophalangeal bilateral joints. Moderate limitation refers to three or more proximal interphalangeal joints or the joint of one finger and one large bilateral joint. Severe cases are constituted by the deformity of the hand at rest or involvement of the cervical spine. The progression of changes, since the initial detection of a mild limitation to moderate or severe condition varies, starting from 3 month to 4 years, with an average of 2 years. Fifty percent of young patients with DM for more than 5 years develop moderate or severe limitation.
There are simple tests that help in its recognition. One is the “prayer sign ”, where it is clearly impossible for the patient to oppose the palms together completely, without leaving a gap between the two; the magnitude will depend on the degree of the patient affectation. The other is the “table top sign” where the patient is not able to completely extend his/her hand on a table’s surface: this makes the diagnosis of metacarpophalangeal contractures easier (Fig. 7.18) (Table 7.3) [27]. If both tests turn out positive, it is recommended to make a careful examination of each joint.
Even though, the prayer sign and the table top sign are widely recognized in literature as diagnostic tools, they are not present in all cases as a rule. For subclinical forms of the disease, goniometry is used which in case of being positive, confirm the association between flexion restriction of small joints of the hands and microvascular complications in patients with DM [28]. In terms of severity assessment, two different classification are used (Tables 7.4 and 7.5) [29].
Cutaneous biopsy is rarely used for the diagnosis of this syndrome. Histopathological findings consist of a normal epidermis and an excess amount of thickened and hyalinized collagen fibers [30].
With regards to the natural evolution, after two decades of its acknowledgement, its incidence has experienced a substantial decrease, probably due to a better metabolic control. In 1998, the same physicians applying the same techniques they used in their description compared the initial findings and found that the frequency of LJM had decreased four times along with a dramatic decrease in other manifestations such as short stature. This important reduction in the frequency in kids and teenagers with DM over time was attributed to a better glycaemia and HbA1c monitoring and to new types and release systems of insulin [31, 32].
In the treatment of LJM, metabolic control is mandatory, in addition to physiotherapy and occupational therapy that can be helpful and yield variable results [33].
Diabetic Scleredema
It is a rare disorder that affects generally older than 40 year-old-male diabetic patients, with an approximate incidence of 2.5%. It is characterized by thickness and diffuse, asymptomatic and symmetric skin induration of the posterior neck and upper back, shoulders and arms, which confers an orange-peel appearance. Although less frequent, it may involve other parts of the body like the face, abdomen, thighs, and buttocks. In contrast to scleroderma, hands and feet are spared [34] (Fig. 7.19).
Nowadays three types of scleredema are described in literature: Type 1 is the classical form or scleredema adultorum of Buschke that mainly affects women and is typically preceded by an infectious process of upper airways most often due to Streptococcus which resolves spontaneously in contrast to Type 3, which is seen in long-standing and poor-controlled T2DM, the so-called Scleredema diabeticorum , which differs from the classical or type 1 Scleredema in its predominance in men, it is not preceded by any infectious process and does not resolve spontaneously, besides it is associated with insulin resistant state and obesity (Table 7.6).
In order to make a correct classification and diagnosis , physicians should take a comprehensive clinical history of the patient, laboratory tests with complete blood count, glycaemia, HbA1c levels, etc. and a skin biopsy to confirm the diagnosis [35].
Microscopically, thickened and irregularly distributed collagen fibers, separated by clear spaces in which mucin is deposited, evidenced with Alcian Blue stain, at the reticular dermis can be observed. Sometimes, the increase of the dermis thickness can reach up to four times its normal size. Moreover, subcutaneous fat can be replaced by collagen fibers [36].
Although there is considerable uncertainty about its pathogenesis, one possibility is that hyperglycemia would act as a stimulant for fibroblast proliferation and synthesis of extracellular matrix components. Another hypothesis is that a poor glycemic control may lead to an increase in NEG of the collagen fibers. The accumulation of AGE-modified collagen, which in turn are more resistant to collagenases degradation, is responsible for the skin induration [37,38,39].
The treatment of SD continues to be a challenge, lacking a gold standard and large placebo controlled trials. Most of the reported cases, achieved variable results. The first therapeutic step is the intensification of the metabolic control, although there is no consensus regarding the correlation between glycemic control and the improvement of SD.
Colchicine has been used in cases of SD, due to its anti-inflammatory properties and to its ability to prevent collagen synthesis [40]. Lin et al. reported a case of an association between SD and eccrine gland loss with the subsequent anhidrosis of the affected area. After 8 month of treatment with allopurinol 100 mg/day a mild relief was noted by the patient but without changes related to the lack of sweating [41].
Immunosuppressant drugs like cyclosporine, corticosteroids (CST) and methotrexate (MTX) are other therapeutic options. It is believed that MTX, apart from interfering in the glycation process, can decrease the production of connective tissue or mucin by the fibroblasts and other cells that are involved [42]. Another therapeutic modality could be radiation therapy, psoralen combined with ultraviolet A (PUVA) (accumulative doses of UVA, 120 J/cm2). Shazzad et al. report a case of a patient with SD treated with a combination of PUVA and MTX with a good results [43]. Recently very good response have been reported with UVA1 phototherapy and intravenous immunoglobulin G (IVIG) [44,45,46,47].
In our experience, although the small number of patients with SD we have observed, cutaneous lesions didn’t improve with a good glycemic control and the therapeutic response to the different modalities described, has been refractory.
As mentioned previously, the diagnosis of thick skin syndrome is basically clinical and there are non-invasive methods of detection like ocular inspection, palpation, the prayer sign and the table top sign. There is another way to check it, which is by detecting cutaneous wrinkles on the finger pads [48]. The patient’s hands are submerged in warm water at 42 °C for 30 min. In diabetic patients, no wrinkles on the finger pads are observed, contrary to what happens in the general population (Fig. 7.20). The mechanism by which these wrinkles diminish, is unknown, but it is thought that the cause of the thickening of this part of the skin could be multifactorial and that sympathetic autonomic neuropathy with an increase in the deep tissue turgor, keratin NEG with an increase in the epidermal thickness, and the alteration of the blood flow through the finger pads, participate.
Conclusion
The thick skin syndrome includes several cutaneous manifestations. Many of them are associated with comorbidities, or in association with other syndromes and should be differentiated from other conditions such Scleroderma.
LJM is an often-missed Diabetes marker that in severe cases may interfere with daily life’s routine. It’s importance lies in the fact that it can be used as a surrogate sign for development of diabetic microvascular complications.
Moreover, it’s association with higher risk of accidental falls, diabetic foot ulcers and upper extremity impairments have been reported many times in the literature.
Fortunately, there is an important decrease in its frequency due to a better glycaemia and HbA1c monitoring and the new types and release systems of insulin. Thus, metabolic control in patients with skin thick syndrome is mandatory.
References
Abate M, Schiavone C, Salini V, et al. Management of limited joint mobility in diabetic patients. Diabetes Metab Syndr Obes. 2013;6:197–207.
Singla R, Gupta Y, Kalra S. Musculoskeletal effects of diabetes mellitus. J Pak Med Assoc. 2015;65(9):1024–7.
Rosenbloom AL. Connective tissue disorders in diabetes. In: Defrongo RA, Ferrannini E, Keen H, Zimmet P, editors. International textbook F diabetes mellitus. 3rd ed. Wiley: Chichester; 2004.
Chen L-H, Li C-Y, Kuo L-C. Risk of hand syndromes in patients with diabetes mellitus: a population-based cohort study in Taiwan. Medicine. 2015;94(41):1575.
Schiavon F, Circhetta C, Dani L. The diabetic hand. Reumatismo. 2004;56(3):139–42.
Gerrits E, Landman G, Nijenhuis-Rosien L, et al. Limited joint mobility syndrome in diabetes mellitus: a mini review. World J Diabetes. 2015;6(9):1108–12.
Larkin ME, Barnie A, Braffett BH, Diabetes control and complications trial/epidemiology of diabetes Interventions and complications research group, et al. Musculoskeletal complications in type 1 diabetes. Diabetes Care. 2014;37(7):1863–9.
Nagesh VS, Kalra S. Type 1 diabetes: syndromes in resource-challenged settings. J Pak Med Assoc. 2015;65(6):681–5; 28.
Burner TW, Rosenthal AK. Diabetes and rheumatic diseases. Curr Opin Rheumatol. 2009;21(1):50–4.
Huntley C. Finger pebbles: a common finding in diabetes mellitus. J Am Acad Dermatol. 1986;14:612–7.
Libecco JF, Brodell RT. Finger pebbles and diabetes: a case with broad involvement of the dorsal fingers and hands. Arch Dermatol. 2001;137(4):510–1.
Singh R, Barden A, Mori T, et al. Advanced glycation end-products: a review. Diabetologia. 2001;44(2):129–46.
Cabo HA, Woscoff A, Casas JG. Empedrado digital: marcador temprano de engrosamiento cutaneo en pacientes diabeticos. Arch Argent Dermatol. 1988;48:185–9.
Guarneri C, Guarneri F, Borgia F, et al. Finger pebbles in a diabetic patient: Huntley’s papules. Int J Dermatol. 2005;44:755–6.
Saraiya A, Al-Shoha A, Brodell RT. Hyperinsulinemia associated with acanthosis nigricans, finger pebbles, acrochordons, and the sign of Leser-Trelat. Endocr Pract. 2013;19(3):522–5.
Hollister DS, Brodell RT. Finger ‘pebbles’A dermatologic sign of diabetes mellitus. Postgrad Med. 2000;107(3):209–10.
Granel B, Serratrice J, Mohamed H, et al. Pickwickian syndrome and vanishing finger pebbles. Arch Dermatol. 2001;137(4):508–10.
Tyndall A, Fistarol S. The differential diagnosis of systemic sclerosis. Curr Opin Rheumatol. 2013;25(6):692–9.
Shah KM, Clark RB, McGill JB, Lang CE, et al. Shoulder limited joint mobility in people with diabetes mellitus. Clin Biomech (Bristol, Avon). 2015;30(3):308–13.
Rosenbloom AL, Frias JL. Diabetes, short stature and joint stiffness—a new syndrome. Clin Res. 1974;22:92A.
Proubasta R. La mano diabética. Revista Iberoamericana de Cirugía de la mano. 2015;43(2):135.
Amin R, Bahu TK, Widmer B, et al. Longitudinal relation between limited joint mobility, height, insulin like growth factor I levels, and risk of developing microalbuminuria: the Oxford Regional Prospective Study. Arch Dis Child. 2005;90:1039–44.
Lopez-Martin I, Benito Ortiz L, Rodriguez-Borlado B, et al. Association between limited joint mobility syndrome and risk of accidental falls in diabetic patients. Semergen. 2015;41(2):70–5.
Mineoka Y, Ishii M, Tsuji A, et al. Relationship between limited joint mobility of the hand and diabetic foot risk in patients with type 2 diabetes. J Diabetes. 2017 Jun;9(6):628–33.
Craig ME, Duffin AC, Gallego PH, et al. Plantar fascia thickness, a measure of tissue glycation, predicts the development of complications in adolescents with type 1 diabetes. Diabetes Care. 2008;31(6):1201–6.
Shah KM, Clark BR, McGill JB, et al. Upper extremity impairments, pain and disability in patients with diabetes mellitus. Physiotherapy. 2015;101(2):147–54.
Rosenbloom AL, Silverstein JH. Connective tissue and joint disease in diabetes mellitus. Endocrinol Metab Clin N Am. 1996;25:473–83.
Pandey A, Usman K, Reddy H, et al. Prevalence of hand disorders in type 2 diabetes mellitus and its correlation with microvascular complications. Ann Med Health Sci Res. 2013;3(3):349–54.
Starkman H, Brink S. Limited joint mobility (LJM) of the hand in patients with diabetes mellitus. Diabetes Care. 1982;5:534–6.
Liu T, McCalmont TH, Frieden IJ, et al. The stiff skin syndrome: case series, differential diagnosis of the stiff skin phenotype, and review of the literature. Arch Dermatol. 2008;144(10):1351–9.
Infante JR, Rosenbloom AL, Silverstein JH, et al. Changes in frequency and severity of limited joint mobility in children with type 1 diabetes mellitus between 1976–78 and 1998. J Pediatr. 2001;138:33–7.
Rosenbloom AL. Limited Joint mobility in childhood diabetes: discovery, description, and decline. J Clin Endocrinol Metab. 2013;98:466–73.
Del Rosso A, Matucci Cerinic M, De Giorgio F, et al. Rheumatological manifestations in diabetes mellitus. Curr Diabetes Rev. 2006;2(4):455–66.
Rebora A, Rongioletti F. Mucinoses. In: Bolognia JL, Jorizzo JL, Rapini RP, editors. Dermatology. London: Mosby; 2003. p. 647–58.
Salazar-Nievas M, Crespo-Lora V, Rubio-Lopez J, et al. Cutaneous indurated plaque on the abdomen associated with diabetes mellitus. Aust Fam Physician. 2013;42(12):876–7.
Beers WH, Ince A, Moore TL. Scleredema adultorum of Buschke: a case report and review of the literature. Semin Arthritis Rheum. 2006;35(6):355–9.
Tran K, Boyd KP, Robinson MR, et al. Scleredema diabeticorum. Dermatol Online J. 2013;19(12):20718.
Gruson LM, Franks A Jr. Scleredema and diabetic sclerodactyly. Dermatol Online J. 2005;11(4):3.
Yaqub A, Chung L, Rieger KE, et al. Localized cutaneous fibrosing disorders. Rheum Dis Clin N Am. 2013;39(2):347–64.
Sapadin AN, Fleischmajer R. Treatment of scleroderma. Arch Dermatol. 2002;138:99.
Lin I-C, Chiu H-Y, Chan J-Y, Lin S-J. Extensive scleredema adultorum with loss of eccrine glands. J Am Acad Dermatol. 2014;71(3):99–101.
Doğramacı AC, Inan MU, Atik E, et al. Scleredema diabeticorum partially treated with low-dose methotrexate: a report of five cases. Balkan Med J. 2012;29(2):218–21.
Shazzad MN, Azad AK, Abdal SJ. Scleredema diabeticorum—a case report. Mymensinghmed J. 2015;24(3):606–9.
Janiga J, Ward DH, Lim HW. UVA-1 as a treatment for scleredema. Photodermatol Photoimmunol Photomed. 2004;20(4):210–1.
Kroff EB, de Jong EM. Scleredema diabeticorum case series: successful treatment with UV-A1. Arch Dermatol. 2008;144(7):947–8.
Kroft E, Berkhof N, van der Kerkhof P, et al. Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review. J Am Acad Dermatol. 2008;59(6):1017–30.
Martin C, Requena L, Manrique K, et al. Scleredema diabeticorum in a patient with type 2 diabetes mellitus. Case Rep Endocrinol. 2011;560:560273. https://doi.org/10.1155/2011/560273.
Clark C, Pentland B, Ewing D, et al. Decreased skin wrinkling in diabetes mellitus. Diabetes Care. 1984;7(3):224–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Sabban, E.N.C., Friedman, P.A. (2018). Thick Skin Syndrome. In: Cohen Sabban, E., Puchulu, F., Cusi, K. (eds) Dermatology and Diabetes. Springer, Cham. https://doi.org/10.1007/978-3-319-72475-1_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-72475-1_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-72474-4
Online ISBN: 978-3-319-72475-1
eBook Packages: MedicineMedicine (R0)